Epsilon M&A Deal Report - Bouvet Ladubay
Transaction Multiples for the Valuation of Private Companies
Private Group led by Ouest Croissance, CM-CIC Investissement and Unigrains / Bouvet Ladubay
- Beverages > Food & Beverage Industry > Wine Production
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
Current | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Wine Production » = 24
Date | Acquirer | Target | Country | Multiples | See details |
15/03/2012 | Omega Pharma | Non-Core OTC Brands of GlaxoSmithKline | Germany | *** | 80635 |
31/05/2016 | Recordati | Italchimici | Italy | ** | 80426 |
Source: Epsilon Research / EMAT